Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
Filed with HKEX · Stock code 858 · · 10 pages · English
Summary by 6ix AI
It confirms the total authorized and registered share capital at the end of the month. The report also includes details on issued shares and treasury shares, confirming compliance with public float requirements. No changes in the number of issued shares or treasury shares were reported during the month.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Extrawell Pharmaceutical Holdings Limited on 6ix
Earlier from Extrawell Pharmaceutical
- Further extension of long stop date in respect of proposed fourth amendments to the terms and conditions of the bonds
- Extrawell Pharmaceutical Holdings: Proposals for general mandates to issue new shares and buy back shares, re-election of retiring directors and notice of annual general meeting
- Extrawell Pharmaceutical Holdings: Major transaction - second amendments to the terms and conditions of the convertible bonds
- Poll results of annual general meeting held on 28 August 2020 and retirement of director
- Extrawell Pharmaceutical Holdings: Proposals for general mandates to issue new shares and buy back shares, re-election of retiring director and notice of annual general meeting
Later from Extrawell Pharmaceutical
- Appointment of executive director
- List of directors and their roles and functions
- Proposed share consolidation; proposed capital Reduction; proposed share sub-division and proposed change in board lot size
- Termination of the memorandum of understanding in relation to the possible sale of the convertible bonds
- Grant of share options to directors and connected transaction at subsidiary level in relation to the grant of share options to the service provider
Follow Extrawell Pharmaceutical into a list and get an email when it puts out news.
Follow Extrawell Pharmaceutical